Prucalshil 1mg Orally Disintegrating Strip
By Prucalshil
Rx
10 Disintegrating Strip in a Boxes

Composition
Prucalopride(1mg)

Manufacturer - Shilpa Medicare Ltd
12-6-214/A1, Hyderabad Road, Raichur – 584 135, Karnataka, India.

Expires on or after
February, 2026

liver
When using Prucalshil 1mg Orally Disintegrating Strip, it is important to be cautious if you have severe liver disease. In such cases, dose adjustment may be necessary, and it is best to consult your doctor before using this medication. There is limited information on the use of Prucalshil 1mg Orally Disintegrating Strip in patients with liver issues, so it is crucial to seek medical advice for proper guidance. For individuals with mild to moderate liver disease, no dose adjustment is typically recommended. If you have liver impairment or liver disease, please consult with your doctor before starting treatment with Prucalshil 1mg Orally Disintegrating Strip.

kidney
Prucalshil 1mg Orally Disintegrating Strip should be used cautiously in patients with severe kidney disease. Dose adjustment may be necessary. Consult your doctor if you have kidney impairment or kidney disease.

alcohol
Consult your doctor when consuming alcohol with Prucalshil 1mg Orally Disintegrating Strip. It's uncertain if there are any interactions, and your doctor's guidance is recommended.

driving
Prucalshil 1mg Orally Disintegrating Strip may cause dizziness and tiredness, affecting driving ability, especially on the first day of use. You may experience these side effects, so be cautious when driving or using machinery. It is advised to drive only when fully alert.

pregnancy
Prucalshil 1mg Orally Disintegrating Strip may pose risks during pregnancy. Limited human studies show harmful effects on the unborn baby, as seen in animal studies. Your doctor will assess benefits versus risks before prescribing. Use contraception, inform your doctor if pregnant or planning pregnancy.

breastfeeding
Prucalshil 1mg Orally Disintegrating Strip may be harmful during breastfeeding as it can pass into breastmilk, potentially harming the baby. To be safe, avoid breastfeeding while using this medication.
| Habit Forming | No |
| Chemical Class | Dihydrobenzofurancarboxamide Derivative {benzamides} |
| Therapeutic Class | GASTRO INTESTINAL |
| Action Class | Serotonin (5-HT4) receptor agonist-Prokinetic agent |
₹198
₹220
10% OFF
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 11-Feb-2025
